Your browser doesn't support javascript.
loading
TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungs.
Deliyannis, Georgia; Wong, Chinn Yi; McQuilten, Hayley A; Bachem, Annabell; Clarke, Michele; Jia, Xiaoxiao; Horrocks, Kylie; Zeng, Weiguang; Girkin, Jason; Scott, Nichollas E; Londrigan, Sarah L; Reading, Patrick C; Bartlett, Nathan W; Kedzierska, Katherine; Brown, Lorena E; Mercuri, Francesca; Demaison, Christophe; Jackson, David C; Chua, Brendon Y.
Afiliação
  • Deliyannis G; Department of Microbiology and Immunology, the University of Melbourne, the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Wong CY; Department of Microbiology and Immunology, the University of Melbourne, the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • McQuilten HA; Department of Microbiology and Immunology, the University of Melbourne, the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Bachem A; Department of Microbiology and Immunology, the University of Melbourne, the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Clarke M; Department of Microbiology and Immunology, the University of Melbourne, the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Jia X; Department of Microbiology and Immunology, the University of Melbourne, the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Horrocks K; Department of Microbiology and Immunology, the University of Melbourne, the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Zeng W; Department of Microbiology and Immunology, the University of Melbourne, the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Girkin J; Viral Immunology and Respiratory Disease group, School of Biomedical Science and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, Australia.
  • Scott NE; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.
  • Londrigan SL; Department of Microbiology and Immunology, the University of Melbourne, the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Reading PC; Department of Microbiology and Immunology, the University of Melbourne, the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Bartlett NW; Department of Microbiology and Immunology, the University of Melbourne, the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Kedzierska K; WHO Collaborating Centre for Reference and Research on Influenza, the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Brown LE; Viral Immunology and Respiratory Disease group, School of Biomedical Science and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, Australia.
  • Mercuri F; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.
  • Demaison C; Department of Microbiology and Immunology, the University of Melbourne, the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Jackson DC; Department of Microbiology and Immunology, the University of Melbourne, the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Chua BY; Ena Respiratory, Melbourne, Victoria, Australia.
JCI Insight ; 6(5)2021 03 08.
Article em En | MEDLINE | ID: mdl-33561017

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Respiratórias / Receptor 2 Toll-Like / Influenza Humana / Lipopeptídeos / Imunidade Inata / Fatores Imunológicos / Pulmão Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Respiratórias / Receptor 2 Toll-Like / Influenza Humana / Lipopeptídeos / Imunidade Inata / Fatores Imunológicos / Pulmão Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália